Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Portadores asintomáticos de hidatidosis

Epidemiología, diagnóstico y tratamiento

Bibliographic Data

ID14966970
AuthorsEdmundo Larrieu (0000-0002-4961-894X, corresponding author), Bernardo Frider (Argerich Hospital), Mario Del Carpio, Juan Carlos Salvitti, Carlos Mercapide, Rubén Pereyra, Maria Costa (0000-0002-3463-0794), Teresa Costa (0000-0002-0823-2936), Martín Odriozola, Alicia Pérez (0000-0002-6796-4168), Gustavo CANTONI, José Sustercic
Year2000
Volume8
Issue4
Pages250-256
Publication date2000-10-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueRevista Panamericana de Salud Pública (JOURNAL)
Journal identifiersISSN: 1020-4989 • E-ISSN: 1680-5348
PublisherFapUNIFESP (SciELO) (PUBLISHER)
DOI10.1590/s1020-49892000000900004
PMID11141967
OpenAlexW2096964800
SCIELO_PIDS1020-49892000000900004
LanguagePT
Citations received1
References cited6

Until a short time ago, hydatidosis was considered a pathology that could only be resolved surgically. However, in recent years progress has been made with the epidemiology, diagnosis, and treatment of the disease, and new information on the natural history of hydatidosis has helped define new criteria for its treatment. It is now known that as many as 67% of the carriers of liver cysts who are asymptomatic remain so throughout their lives. This situation produces special results in immunologic testing. Enzyme-linked immunosorbent assay (ELISA) has a sensitivity of 63% and a specificity of 97% with asymptomatic carriers, while the double diffusion arc 5 test (DD5) achieves a sensitivity of only 31% with the same population. On the other hand, imaging studies based on ultrasonography have become the method of choice to detect asymptomatic carriers. Ultrasonography studies are 49% to 73% more sensitive than serological tests, and they can even be used as a part of epidemiological surveillance systems and to monitor control programs. Treatment schemes have also been modernized. Treating asymptomatic carriers chemotherapeutically with albendazole produces favorable results in as many as 69% of cases, while such minimally invasive surgical treatments as puncture-aspiration-injection-reaspiration (PAIR) reduce average cyst volume by as much as 66%. These factors have made it possible for hospital services in the province of Río Negro, Argentina, to establish a treatment scheme for asymptomatic carriers. It is based on the monitoring of small cysts (type Ia on the modified Gharbi scale); initial treatment with albendazole, followed by PAIR if there is no response, in larger or more complex cysts (types Ib, II, and III); and follow-up of inviable or dead cysts (types IV and V)

Humanities · Congenital Anomalies and Fetal Surgery · Medicine · Parasite Biology and Host Interactions · Parasitic infections in humans and animals · Philosophy

  • Evaluación de dos pruebas de inmunoblot con antígeno hidatídico de caprino y ovino para el diagnóstico de equinococosis humana

    Open Access•Eduardo Miranda-Ulloa, Eduardo Miranda et al.•Revista Peruana de Medicina…•2010

  • Comparison of two serologic methods for the diagnosis of hydatidosis

    Open Access•Héctor M Arienti, Susana I Guignard et al.•Revista Panamericana de Salud…•1997

Unique citing works1
Citations per year0,06
Citation span2010 - 2010 (1)
Citation velocityhistorical
Highly citedNo
Citation typesNeutral: 1

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae